Pathogenic effects of agrin V1727F mutation are isoform specific and decrease its expression and affinity for HSPGs and LRP4
Open Access
- 17 April 2019
- journal article
- research article
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 28 (16) , 2648-2658
Abstract
Agrin is a large extracellular matrix protein whose isoforms differ in their tissue distribution and function. Motoneuron-derived y+z+ agrin regulates the formation of the neuromuscular junction (NMJ), while y−z− agrin is widely expressed and has diverse functions. Previously we identified a missense mutation (V1727F) in the second laminin globular (LG2) domain of agrin that causes severe congenital myasthenic syndrome. Here, we define pathogenic effects of the agrin V1727F mutation that account for the profound dysfunction of the NMJ. First, by expressing agrin variants in heterologous cells, we show that the V1727F mutation reduces the secretion of y+z+ agrin compared to wild type, whereas it has no effect on the secretion of y−z− agrin. Second, we find that the V1727F mutation significantly impairs binding of y+z+ agrin to both heparin and the low-density lipoprotein receptor-related protein 4 (LRP4) coreceptor. Third, molecular modeling of the LG2 domain suggests that the V1727F mutation primarily disrupts the y splice insert, and consistent with this we find that it partially occludes the contribution of the y splice insert to agrin binding to heparin and LRP4. Together, these findings identify several pathogenic effects of the V1727F mutation that reduce its expression and ability to bind heparan sulfate proteoglycan and LRP4 coreceptors involved in the muscle-specific kinase signaling pathway. These defects primarily impair the function of neural y+z+ agrin and combine to cause a severe CMS phenotype, whereas y−z− agrin function in other tissues appears preserved.Keywords
Funding Information
- National Institutes of Health (R01NS049117)
This publication has 63 references indexed in Scilit:
- A Pareto-Optimal Refinement Method for Protein Design ScaffoldsPLOS ONE, 2013
- The Structure of Neurexin 1α Reveals Features Promoting a Role as Synaptic OrganizerStructure, 2011
- Alternate States of Proteins Revealed by Detailed Energy Landscape MappingJournal of Molecular Biology, 2011
- Identification of an Agrin Mutation that Causes Congenital Myasthenia and Affects Synapse FunctionThe American Journal of Human Genetics, 2009
- LRP4 Serves as a Coreceptor of AgrinNeuron, 2008
- Lrp4 Is a Receptor for Agrin and Forms a Complex with MuSKCell, 2008
- Synapse disassembly and formation of new synapses in postnatal muscle upon conditional inactivation of MuSKMolecular and Cellular Neuroscience, 2006
- UCSF Chimera—A visualization system for exploratory research and analysisJournal of Computational Chemistry, 2004
- The Receptor Tyrosine Kinase MuSK Is Required for Neuromuscular Junction Formation In VivoCell, 1996
- The ability of agrin to cluster AChRs depends on alternative splicing and on cell surface proteoglycansNeuron, 1993